| Monday, September 24, 2007 |
| 09:30:00 |
Pre-Conference Workshop: Workshop Registration (09:30-10:00) |
|
| 10:00:00 |
Pre-Conference Workshop: GE Healthcare IN Cell Analyzer Technology Workshop (10:00-12:00) |
Liz Roquemore, Jacob Tesdorpf, Robert Graves
|
| 16:30:00 |
Early Conference Registration (16:30-17:30) |
|
| Tuesday, September 25, 2007 |
| 07:30:00 |
Conference Registration (07:30-08:30) |
|
| 08:30:00 |
Welcoming Remarks from Conference Director (08:30-08:40) |
Julia Boguslavsky
|
| 08:40:00 |
HCA for Compound Screening: Case Study - Monitoring of Chemokine Receptor Activation Using High-Content Screening (08:40-09:10) Case Study |
Ralf Heilker
|
| 08:40:00 |
HCA for Compound Screening (08:40-1130) |
Marcel B. Bally, Koen Van Acker, Ralf Heilker
|
| 09:10:00 |
HCA for Compound Screening: Identification of HIV-1 Entry Fusion Inhibitors Using a Homogeneous Competitive Cell-Based Binding Assay on a High-Content Screening Platform(09:10-09:40) |
Koen Van Acker
|
| 09:40:00 |
HCA for Compound Screening: HCS Assays for Assessing Anticancer Drug Combination Effects (09:40-10:10) |
Marcel B. Bally
|
| 10:10:00 |
HCA for Compound Screening: To be Announced (10:10-10:40) |
|
| 10:40:00 |
HCA for Compound Screening: Coffee Break with Poster and Exhibit Viewing (10:40-11:30) |
|
| 11:30:00 |
New Technology Showcase (11:30-14:00) |
Kris Ver Donck, Mark Collins, Michael A Mancini
|
| 11:30:00 |
New Technology Showcase: Get RAD-icle - Overcoming the Assay Optimization Bottleneck in HCS (11:30-11:45) |
Mark Collins
|
| 11:45:00 |
New Technology Showcase: Multiplex Analyses of Nuclear Receptor Function by High Throughput Imaging (11:45-12:00) |
Michael A Mancini
|
| 12:00:00 |
New Technology Showcase: New Developments in HCS Screening Related to Brightfield, Automated User Defined Focus Points and Unique Data Mining Tools for Increased Data Quality and Assessment (12:00-12:15) |
Kris Ver Donck
|
| 12:15:00 |
New Technology Showcase: Technology Short Talk (12:15-12:30) |
|
| 12:30:00 |
New Technology Showcase: Lunch on Your Own (12:30-14:00) |
|
| 14:00:00 |
HCA for Toxicity and Efficacy Assessment: Use of HCA for Translational Safety Biomarkers (14:00-14:30) |
Peter O'Brien
|
| 14:00:00 |
HCA for Toxicity and Efficacy Assessment (14:00-16:00) |
Peter O'Brien, Anthony Davies
|
| 14:30:00 |
HCA for Toxicity and Efficacy Assessment: Development of Cell-Based Assays for Study of Cardiac Disease and Drug Efficacy and Toxicity Using Primary Cardiomyocytes and Cardiac-Derived Cell Lines in a High-Content Format (14:30-15:00) |
Anthony Davies
|
| 15:00:00 |
HCA for Toxicity and Efficacy Assessment: Refreshment Break with Poster and Exhibit Viewing (15:00-16:00) |
|
| 16:00:00 |
HCA for Mechanism-of-Action Studies: Use of the BD Pathway in CNS Drug Discovery to Determine Mechanisms of Compound Action in Primary Neuronal Cultures (16:00-16:30) |
Claire Scott
|
| 16:00:00 |
HCA for Mechanism-of-Action Studies (16:00-18:00) |
Philip Denner, Claire Scott
|
| 16:30:00 |
HCA for Mechanism-of-Action Studies: Development of Automated Image Analysis Routines for Functional HCA (16:30-17:00) |
Philip Denner
|
| 17:00:00 |
HCA for Mechanism-of-Action Studies: Cocktail Reception with Exhibit and Poster Viewing (17:00-18:00) |
|
| Wednesday, September 26, 2007 |
| 07:30:00 |
Breakfast Technology Workshop Quantitative Imaging Approaches in Drug Discovery (07:30-08:15) |
Werner Stürmer
|
| 08:30:00 |
ThinkTank Roundtable Discussions (08:30-09:30) |
|
| 09:30:00 |
Coffee Break with Exhibit and Poster Viewing (09:30-10:15) |
|
| 10:15:00 |
HCA for RNAi Screening: Large-Scale siRNA Screening for Functional Genomics in Endocytosis (10:15-10:45) |
Martin Stöter
|
| 10:15:00 |
HCA for RNAi Screening (10:15-12:15) |
Martin Stöter, Remko de Pril, Anja van Brabant-Smith, Michael Hannus
|
| 10:45:00 |
HCA for RNAi Screening: Identification of Novel Anti-Malarial Targets and Lead Compounds Using High-Content Microscopy Assay for RNAi and Drug Screens (10:45-11:15) |
Michael Hannus
|
| 11:15:00 |
HCA for RNAi Screening: A High-Content Assay Reveals the Potential Role of microRNA Clusters in Cell Growth and Transformation (11:15-11:45) |
Anja van Brabant-Smith
|
| 11:45:00 |
HCA for RNAi Screening: Drugable Genome-Wide RNAi Screen in Huntington Disease Applying High-Content Analysis (11:45-12:15) |
Remko de Pril
|
| 12:15:00 |
Close of Conference |
|
How We Rank